Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US posted Q2 2026 net income of about $170M ($2.71/share) and adjusted EBITDA of about $639M, with an RVO-adjusted EBITDA of $490M (RVO-adjusted EPS: $3.64/share). Logistics delivered a record $144M in adjusted EBITDA, and the company reaffirmed 2026 DKL EBITDA guidance of $520M–$560M while raising/maintaining a disciplined capital plan (about $16M dividends and $20M buybacks in the quarter; ~10% repurchased since early 2025). Refining Q3 throughput guidance totals 296k–316k bpd and net interest expense is guided to $75M–$85M; management also highlighted rising mid-cycle free cash flow confidence of $650M–$700M and continued efforts to secure 2025 small refinery exemptions (SREs) to mitigate elevated RVO compliance costs.

Analysis

The cleanest takeaway is that the equity story is shifting away from “refining beta” toward a two-part valuation: a cyclical refiner with policy noise on one side, and an increasingly self-contained midstream cash machine on the other. That matters because the market will likely underwrite DKL more like a growth/logistics asset if third-party EBITDA continues to dominate, while DK should trade on the residual refining complexity and the optionality of capital return rather than on headline earnings alone.

In the next 1-3 months, the setup is less one-way than the print suggests. A flatter forward curve should mechanically reduce near-term margin capture versus the prior quarter, so a strong reported period may be more of a peak-earnings reference point than a new run-rate. The upside catalyst is regulatory, but SRE timing is binary and the cash realization path may be messy; if the market is already capitalizing a large retroactive benefit, any delay or partial award could compress the multiple quickly.

Over 6-18 months, the real rerating lever is sum-of-the-parts execution. If management keeps shrinking net debt while DKL compounds and the parent continues repurchases, DK can de-lever into a cleaner equity story, but that also makes the stock more sensitive to any EOP disappointment or refinery outage. Contrarian view: consensus is likely overestimating the importance of SRE cash and underestimating how much the current mix shift, logistics separation, and capital return policy can lift the parent’s intrinsic value even if refining margins normalize.

Key Decisions for Investors

• Long DKL vs short DK for 1-3 months: express the view that the midstream asset deserves a premium while the parent still carries refining and regulatory noise; target is multiple divergence if DKL continues to de-risk and DK remains policy-sensitive.
• If owning DK outright, wait for either a pullback on weaker Q3 margin setup or confirmation on SRE timing before adding; the near-term risk/reward is worse if the market is already pricing peak margins and full regulatory relief.
• Use a call spread in DK only if you want SRE convexity without full downside exposure; the trade works only if an award lands within the next 1-2 quarters, otherwise theta will erode the thesis.
• Watch DKL as the higher-quality long in the group; add on any weakness if third-party EBITDA and deconsolidation progress continue, because that is the more durable 6-18 month rerating driver.
• Pair idea for the sector: long DKL / short a pure refining proxy such as PBF or CLMT if you expect backwardation normalization to compress refining margins faster than midstream cash flows decelerate.